Port Louis [Mauritius], March 19 (ANI): In a unified attempt to free the world of coronavirus, India on Friday handed over to Mauritius a commercial supply of 200,000 doses of Covaxin vaccines under the 'Vaccine Maitri' initiative.
Port Louis [Mauritius], March 19 (ANI): Mauritius will receive a consignment of Covaxin, India's indigenously developed COVID-19 vaccine, on Friday, announced the High Commission of India in Port Louis on Thursday.
New Delhi [India], March 17 (ANI): Ambassadors of Paraguay and Costa Rica have hailed India's initiative to supply vaccines to other countries as part of efforts to fight the COVID-19 crisis and said they were looking forward to getting India-made vaccines.
New Delhi [India], March 17 (ANI): External Affairs Minister S Jaishankar on Wednesday said he was proud to have taken 'Covaxin' and recalled that questions were raised when the indigenous COVID-19 vaccine manufactured by Bharat Biotech came to the market earlier this year.
New Delhi [India], March 10 (ANI): The Subject expert committee (SEC) of Drugs Controller General of India (DCGI) on Wednesday recommended removing the "clinical trial mode" condition related to Bharat Biotech's Covaxin.
New Delhi [India], March 9 (ANI): British medical journal The Lancet on Tuesday published the phase 2 results of the "Made in India" COVID-19 vaccine, COVAXIN, stating that the vaccine has better reactogenicity and safety outcomes, and enhanced humoral and cell-mediated immune responses c
Mohali (Punjab) [India], March 5 (ANI): Punjab Chief Minister Captain Amarinder Singh on Friday trashed the Bharatiya Janata Party's allegation of Congress-ruled states rejecting COVAXIN and termed it 'a complete lie' and 'part of the ruling party's false and politically motivated propaganda
New Delhi [India], March 3 (ANI): Phase three results of the COVAXIN, a vaccine against COVID-19 which has been developed by Indian Council of Medical Research (ICMR) in partnership with Bharat Biotech International Limited (BBIL), has shown an interim vaccine efficacy of 81 per cent in p
Hyderabad (Telangana) [India], March 3 (ANI): Bharat Biotech on Wednesday released results of Phase 3 clinical trials of its coronavirus vaccine Covaxin, with the drug demonstrating 81 per cent interim efficacy against Covid-19.
New Delhi [India], March 2 (ANI): A Delhi-based businessman, Rohit Datta on Monday shared his experience and elaborated about how it felt to be the first COVID-19 patient in Delhi and how it felt conquering the virus.